SCHEDULE 13D: Activist Investor Gary Rosenbach Discloses 28.8% Stake in Harte Hanks Inc. Amidst Share Price Decline
Schedule 13D Filing
Gary Rosenbach, a retired individual investor, has disclosed a significant 28.8% beneficial ownership in Harte Hanks Inc. through a Schedule 13D filing, detailing extensive trading activity and a cooperation agreement with the Issuer.
Summary
- Gary S. Rosenbach, a retired individual, has filed a Schedule 13D disclosing his beneficial ownership in Harte Hanks Inc. (the "Issuer").
- As of the filing date (May 30, 2025), Mr. Rosenbach beneficially owns 2,118,635 shares of Common Stock, representing 28.8% of the Issuer's outstanding shares.
- The aggregate purchase price for the shares reported was approximately $12,032,692, acquired using Mr. Rosenbach's personal funds.
- Mr. Rosenbach initially crossed the 5.0% beneficial ownership threshold on April 17, 2023, holding 375,175 shares at that time.
- All transactions were effectuated in the open market through a broker, with detailed purchase and sale history provided from February 16, 2023, through May 1, 2025.
- On May 14, 2025, Rosenbach entered into a Cooperation Agreement with Harte Hanks Inc., which includes customary standstill provisions and a voting agreement.
- Under the Cooperation Agreement, Rosenbach is prohibited from soliciting proxies, advising on voting/disposition (with limited exceptions), and acquiring additional shares.
- Rosenbach has agreed to vote all beneficially owned shares in accordance with the Board's recommendations at all stockholder meetings until the conclusion of the Issuer's 2026 annual meeting, except for Extraordinary Transactions.
- The Cooperation Agreement terminates when Rosenbach ceases to beneficially own 10% or more of the issued and outstanding shares.
- Mr. Rosenbach acquired the securities believing they represented an attractive investment opportunity, and the shares were not acquired for the purpose of changing or influencing control of the Issuer.
Sentiment
Score: 4
Explanation: The investor expresses a belief in an 'attractive investment opportunity,' which is positive. However, the detailed trading history reveals a significant decline in the share price over the period of their investment activity, which is a negative outcome. The cooperation agreement introduces limitations on the investor's influence, balancing the sentiment towards neutral to slightly negative based on the observed price performance.
Positives
- The Reporting Person acquired the securities because he believed they represented an attractive investment opportunity, indicating a positive long-term view of the Issuer.
- The entry into a Cooperation Agreement with the Issuer suggests a collaborative approach rather than an immediate activist stance, potentially providing stability.
Negatives
- The share price of Harte Hanks Inc. experienced a significant decline during the period of the reported transactions, falling from a high of approximately $11.70 per share in February 2023 to a low of approximately $4.30 per share in March 2025, and ending around $4.90 per share by May 2025.
- The Cooperation Agreement includes standstill provisions that prohibit the Reporting Person from acquiring additional shares and limit their ability to influence the Issuer's control or solicit proxies, which could be seen as a limitation on potential upside from activist engagement.
Risks
- The Reporting Person's future investment actions are subject to various factors, including the Issuer's financial position, strategic direction, actions by the Board, share price levels, liquidity requirements, other investment opportunities, securities market conditions, and general economic and industry conditions.
- The Cooperation Agreement restricts the Reporting Person's ability to acquire additional shares or engage in certain activist behaviors, potentially limiting their flexibility to react to market changes or pursue alternative strategies.
Future Outlook
The Reporting Person intends to continuously review his investment in Harte Hanks Inc. Future actions, including potential purchases or sales of shares, will depend on various factors such as the Issuer's financial position, strategic direction, Board actions, share price levels, liquidity needs, other investment opportunities, and general market conditions, all while complying with the Cooperation Agreement and applicable securities laws.
Industry Context
This filing is a standard disclosure of a significant ownership stake by an individual investor. It does not provide broader industry trends or competitive analysis, focusing solely on the investor's position and intentions regarding Harte Hanks Inc.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Cooperation Agreement | Rosenbach entered into a Cooperation Agreement with the Issuer, which includes customary standstill provisions prohibiting proxy solicitation, advising on voting/disposition (with exceptions), and acquiring additional shares. | May 14, 2025 | Limits the investor's ability to actively influence corporate control or strategy, potentially promoting stability but restricting activist potential. Requires the investor to vote in line with Board recommendations for most matters until the 2026 annual meeting. |
| Voting Agreement | Rosenbach agreed to vote all beneficially owned shares in accordance with the Board's recommendations at all stockholder meetings, with an exception for Extraordinary Transactions. | May 14, 2025 | Aligns a significant shareholder's voting power with the current Board, reinforcing existing governance structures and potentially reducing shareholder dissent. |
Stakeholder Impact
- Shareholders: The significant stake and the cooperation agreement, particularly the voting provisions, can influence future shareholder votes and the perception of stability or potential for activist intervention.
- Management/Board: The standstill and voting agreements provide a degree of certainty and stability for the current management and Board by limiting direct challenges from this significant investor.
Next Steps
- The Reporting Person will continue to review his investment in Harte Hanks Inc. on an ongoing basis.
- Future actions may include purchasing or selling shares or related instruments, subject to the Cooperation Agreement and securities laws.
Key Dates
| Date | Description |
|---|---|
| 02/16/2023 | Start date of the 60-day period prior to the event requiring filing, marking the beginning of the detailed trading history in Schedule A. |
| 04/17/2023 | Date of event which required the filing of this statement, when the Reporting Person was deemed to beneficially own 5.0% of the Shares outstanding. |
| 03/31/2023 | Date for which 7,485,170 shares outstanding were disclosed in the Issuer's Definitive Proxy Statement on Schedule 14A, used for calculating beneficial ownership as of April 17, 2023. |
| 04/30/2025 | Date for which 7,364,430 shares outstanding were disclosed in the Issuer's Quarterly Report on Form 10-Q, used for calculating current beneficial ownership percentage. |
| 05/14/2025 | Effective Date of the Cooperation Agreement between Rosenbach and Harte Hanks Inc. |
| 05/30/2025 | Date of the filing of this Schedule 13D statement. |
| 2026 | Conclusion of the Issuer's 2026 annual meeting, marking the termination point for Rosenbach's voting agreement under the Cooperation Agreement. |
Keywords
Harte Hanks Inc., Schedule 13D, Beneficial Ownership, Gary S. Rosenbach, Common Stock, Investment Opportunity, Cooperation Agreement, Standstill Provisions, Voting Agreement, SEC Filing, Shareholder Activity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.